CoChat

Intranasal administration of the GHRP hexarelin accelerates growth in short children

Laron, Z., Frenkel, J., Deghenghl, R., Anin, S., Klinger, B., Siibergeld, A. · 1995 · Clinical Endocrinology
Cited by 80

The DOI matches its Crossref record.

Abstract

Summary: OBJECTIVE Hexarelin is a recently synthesized small growth hormone releasing peptide (GHRP) (His‐D‐methyl‐Trp‐Ala‐Trp‐D‐Phe‐Lys‐NH2). It Is actlve by intra‐venous, oral and intranasal administration In animals and man. The aim of this study was to find out whether longterm administration of this peptlde would promote growth In short chlldren. DESIGN AND PATIENTS intranasal hexareiin was administered in a dose of 60 pglkg thrice dally to 8 prepubertal short children aged 4‐11‐6 years for perlods of up to months. RESULTS Hexarelln treatment stimulated Insulin‐like growth factor‐i (IGF‐I) secretion ralsing the level from 10.4 ± 3.9 (SD) to 141 f 46 nmoill (P < 0.004). The rise IGF‐l led to a significant Increase In the mean (±SD) linear growth velocity from 53 ± 08 to 8 3 ± 1.7 cm/year (P < 0.0001). There was also a slgniflcant decrease skinfold thickness despite Increase in body weight and an Increase in head circumference. Additional flndlngs were a rlse in serum phosphate from 1–5 ± 01 to 1–8 ± 01 mmoi/l (P < 0004) and of aikallne phosphatase from 219 ± 74 to 261 ± 75 U/l (P < 005). CONCLUSIONS The long‐term GHIIGF‐I stimulating, anabolic and growth promoting effects achieved by intranasai administration of this hexapeptide, seemingly without undeslrable slde‐effects, suggests clinical potential for this new class of drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1995.tb02929.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 80

Metadata

Authors
Laron, Z., Frenkel, J., Deghenghl, R., Anin, S., Klinger, B., & Siibergeld, A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1995-11
Volume
43
Issue
5
Pages
631-635
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1998300019
Cited by
80
References
0
FWCI
4.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal administration of the GHRP hexarelin accelerates growth in short children. https://app.cochat.ai/papers/10.1111/j.1365-2265.1995.tb02929.x
The paper
Laron, Z., Frenkel, J., Deghenghl, R., Anin, S., Klinger, B., & Siibergeld, A. (1995). Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1995.tb02929.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.